NEW YORK (GenomeWeb News) – The MD Anderson Cancer Center has licensed GeneGo’s MetaCore data analysis suite for use throughout the institution, the systems biology software company said today.
The St. Joseph, Mich.-based company said MD Anderson will use the suite, which includes training and support, as a central data repository, as a management and collaboration platform for clinical ‘omics data, and for integrative pathway analysis.
MD Anderson pathologist Mary Edgerton said she will use the software to infer networks for pathways in lung, brain, and breast cancer from gene expression array data. She said she also uses the curated pathways to develop mathematical models of molecular networks that predict tumor behavior using multi-scale modeling.”
Financial terms of the agreement were not released.